T1	AdverseReaction 83 93	Infections
T2	AdverseReaction 140 152	Malignancies
T3	AdverseReaction 264 297	upper respiratory tract infection
T4	AdverseReaction 299 314	viral infection
T5	AdverseReaction 316 326	bronchitis
T6	AdverseReaction 328 340	hypertension
T7	AdverseReaction 346 350	rash
T8	AdverseReaction 1788 1821	Upper respiratory tract infection
T9	AdverseReaction 2046 2056	infections
T10	Severity 2038 2045	Serious
T11	AdverseReaction 2108 2114	sepsis
T12	AdverseReaction 2116 2125	pneumonia
T13	AdverseReaction 2127 2137	cellulitis
T14	AdverseReaction 2139 2146	abscess
T15	AdverseReaction 2148 2172	opportunistic infections
T16	AdverseReaction 2174 2186	tuberculosis
T17	AdverseReaction 2197 2223	invasive fungal infections
T18	AdverseReaction 2234 2236	TB
T19	AdverseReaction 2246 2255;2275 2277	pulmonary TB
T20	AdverseReaction 2260 2277	extrapulmonary TB
T21	AdverseReaction 2463 2473	infections
T22	AdverseReaction 2587 2597	infections
T23	Severity 2579 2586	serious
T24	AdverseReaction 2733 2743	infections
T25	Severity 2725 2732	serious
T26	AdverseReaction 3295 3304	active TB
T27	AdverseReaction 3384 3408	opportunistic infections
T28	AdverseReaction 3501 3511	malignancy
T29	AdverseReaction 3523 3531	lymphoma
T30	AdverseReaction 3536 3540	NMSC
T31	AdverseReaction 3781 3785	NMSC
T32	AdverseReaction 3768 3776	lymphoma
T33	AdverseReaction 3867 3871	NMSC
T34	Severity 3967 3973	severe
T35	AdverseReaction 3974 3991	hepatic reactions
T36	AdverseReaction 4002 4021	acute liver failure
T37	DrugClass 4044 4056	TNF-blockers
T38	AdverseReaction 4115 4129	ALT elevations
T39	Severity 4133 4140	5 * ULN
T40	AdverseReaction 4230 4244	ALT elevations
T41	Severity 4248 4255	3 * ULN
T42	DrugClass 4705 4717	TNF-blockers
T43	AdverseReaction 4783 4810	formation of autoantibodies
T44	AdverseReaction 4850 4869	lupus-like syndrome
T45	AdverseReaction 4968 4986	newly ANA-positive
T46	Severity 4988 5006	at titers of 1:160
T47	Negation 5076 5078	no
T48	AdverseReaction 5108 5144	newly positive anti-dsDNA antibodies
T49	AdverseReaction 5292 5309	infusion reaction
T50	AdverseReaction 5435 5439	rash
T51	Negation 5441 5443	No
T52	AdverseReaction 5452 5470	infusion reactions
T53	AdverseReaction 7612 7645	Upper respiratory tract infection
T54	AdverseReaction 7655 7688	upper respiratory tract infection
T55	AdverseReaction 7690 7705	nasopharyngitis
T56	AdverseReaction 7707 7718	pharyngitis
T57	AdverseReaction 7720 7730	laryngitis
T58	AdverseReaction 7736 7744	rhinitis
T59	AdverseReaction 7807 7823	Viral infections
T60	AdverseReaction 7833 7842	influenza
T61	AdverseReaction 7847 7853	herpes
T62	AdverseReaction 7916 7936	Bacterial infections
T63	AdverseReaction 8025 8035	Bronchitis
T64	AdverseReaction 8133 8151	Vascular disorders
T65	AdverseReaction 8243 8255	Hypertension
T66	AdverseReaction 8461 8465	Rash
T67	AdverseReaction 8685 8692	Pyrexia
T70	AdverseReaction 8793 8798;8813 8822	Blood disorders
T71	AdverseReaction 8803 8822	lymphatic disorders
T72	AdverseReaction 9381 9409	Superficial fungal infection
T73	AdverseReaction 9411 9420	sinusitis
T74	AdverseReaction 9422 9429	abscess
T75	AdverseReaction 9431 9464	lower respiratory tract infection
T76	AdverseReaction 9466 9475	pneumonia
T77	AdverseReaction 9478 9492	pyelonephritis
T78	AdverseReaction 9517 9551	Alanine aminotransferase increased
T79	AdverseReaction 9553 9589	aspartate aminotransferase increased
T80	AdverseReaction 9591 9617	neutrophil count decreased
T81	AdverseReaction 9652 9661	Dizziness
T82	AdverseReaction 9663 9674	paresthesia
T83	AdverseReaction 9711 9723	Constipation
T84	AdverseReaction 10199 10207	Melanoma
T85	AdverseReaction 10292 10327	systemic hypersensitivity reactions
T86	AdverseReaction 10339 10360	anaphylactic reaction
T87	AdverseReaction 10407 10418	sarcoidosis
T88	AdverseReaction 10476 10501	Interstitial lung disease
T89	AdverseReaction 10550 10566	Skin exfoliation
T90	AdverseReaction 10568 10590	bullous skin reactions
T91	Severity 75 82	Serious
T92	AdverseReaction 2188 2190	TB
T93	AdverseReaction 2299 2301	TB
T94	Severity 3064 3071	serious
T95	AdverseReaction 3072 3082	infections
T96	AdverseReaction 3721 3733	malignancies
T97	Severity 5444 5451	serious
T98	AdverseReaction 8903 8913	Leukopenia
T99	Severity 10284 10291	Serious
E1	AdverseReaction:T1 Effect:E91
E2	AdverseReaction:T2
E3	AdverseReaction:T3
E4	AdverseReaction:T4
E5	AdverseReaction:T5
E6	AdverseReaction:T6
E7	AdverseReaction:T7
E8	AdverseReaction:T8
E9	AdverseReaction:T9 Effect:E10
E10	Severity:T10
E11	AdverseReaction:T11
E12	AdverseReaction:T12
E13	AdverseReaction:T13
E14	AdverseReaction:T14
E15	AdverseReaction:T15
E16	AdverseReaction:T16
E17	AdverseReaction:T17
E18	AdverseReaction:T18
E19	AdverseReaction:T19
E20	AdverseReaction:T20
E21	AdverseReaction:T21
E22	AdverseReaction:T22 Effect:E23
E23	Severity:T23
E24	AdverseReaction:T24 Effect:E25
E25	Severity:T25
E26	AdverseReaction:T26
E27	AdverseReaction:T27
E28	AdverseReaction:T28
E29	AdverseReaction:T29
E30	AdverseReaction:T30
E31	AdverseReaction:T31
E32	AdverseReaction:T32
E33	AdverseReaction:T33
E34	Severity:T34
E35	AdverseReaction:T35 Effect:E34 Hypothetical:E37
E36	AdverseReaction:T36 Hypothetical:E37
E37	DrugClass:T37
E38	AdverseReaction:T38 Effect:E39
E39	Severity:T39
E40	AdverseReaction:T40 Effect:E41
E41	Severity:T41
E42	DrugClass:T42
E43	AdverseReaction:T43 Hypothetical:E42
E44	AdverseReaction:T44 Hypothetical:E42
E45	AdverseReaction:T45 Effect:E46
E46	Severity:T46
E47	Negation:T47
E48	AdverseReaction:T48 Negated:E47
E49	AdverseReaction:T49
E50	AdverseReaction:T50
E51	Negation:T51
E52	AdverseReaction:T52 Negated:E51 Effect:E97
E53	AdverseReaction:T53
E54	AdverseReaction:T54
E55	AdverseReaction:T55
E56	AdverseReaction:T56
E57	AdverseReaction:T57
E58	AdverseReaction:T58
E59	AdverseReaction:T59
E60	AdverseReaction:T60
E61	AdverseReaction:T61
E62	AdverseReaction:T62
E63	AdverseReaction:T63
E64	AdverseReaction:T64
E65	AdverseReaction:T65
E66	AdverseReaction:T66
E67	AdverseReaction:T67
E70	AdverseReaction:T70
E71	AdverseReaction:T71
E72	AdverseReaction:T72
E73	AdverseReaction:T73
E74	AdverseReaction:T74
E75	AdverseReaction:T75
E76	AdverseReaction:T76
E77	AdverseReaction:T77
E78	AdverseReaction:T78
E79	AdverseReaction:T79
E80	AdverseReaction:T80
E81	AdverseReaction:T81
E82	AdverseReaction:T82
E83	AdverseReaction:T83
E84	AdverseReaction:T84
E85	AdverseReaction:T85 Effect:E99
E86	AdverseReaction:T86
E87	AdverseReaction:T87
E88	AdverseReaction:T88
E89	AdverseReaction:T89
E90	AdverseReaction:T90
E91	Severity:T91
E92	AdverseReaction:T92
E93	AdverseReaction:T93
E94	Severity:T94
E95	AdverseReaction:T95 Effect:E94
E96	AdverseReaction:T96
E97	Severity:T97
E98	AdverseReaction:T98
E99	Severity:T99
A1	CUI E1 C3714514
A2	UMLS-Preferred-Name E1 Infection
A3	MEDDRA-PT E1 Infection
A4	MEDDRA-PT-ID E1 10021789
A5	CUI E2 C0006826
A6	UMLS-Preferred-Name E2 Malignant Neoplasms
A7	MEDDRA-PT E2 Neoplasm malignant
A8	MEDDRA-PT-ID E2 10028997
A9	CUI E3 C0041912
A10	UMLS-Preferred-Name E3 Upper Respiratory Infections
A11	MEDDRA-PT E3 Upper respiratory tract infection
A12	MEDDRA-PT-ID E3 10046306
A13	CUI E4 C0042769
A14	UMLS-Preferred-Name E4 Virus Diseases
A15	MEDDRA-PT E4 Viral infection
A16	MEDDRA-PT-ID E4 10047461
A17	CUI E5 C0006277
A18	UMLS-Preferred-Name E5 Bronchitis
A19	MEDDRA-PT E5 Bronchitis
A20	MEDDRA-PT-ID E5 10006451
A21	CUI E6 C0020538
A22	UMLS-Preferred-Name E6 Hypertensive disease
A23	MEDDRA-PT E6 Hypertension
A24	MEDDRA-PT-ID E6 10020772
A25	CUI E7 C0015230
A26	UMLS-Preferred-Name E7 Exanthema
A27	MEDDRA-PT E7 Rash
A28	MEDDRA-PT-ID E7 10037844
A29	CUI E8 C0041912
A30	UMLS-Preferred-Name E8 Upper Respiratory Infections
A31	MEDDRA-PT E8 Upper respiratory tract infection
A32	MEDDRA-PT-ID E8 10046306
A33	CUI E9 C3714514
A34	UMLS-Preferred-Name E9 Infection
A35	MEDDRA-PT E9 Infection
A36	MEDDRA-PT-ID E9 10021789
A37	CUI E11 C0243026
A38	UMLS-Preferred-Name E11 Sepsis
A39	MEDDRA-PT E11 Sepsis
A40	MEDDRA-PT-ID E11 10040047
A41	CUI E12 C0032285
A42	UMLS-Preferred-Name E12 Pneumonia
A43	MEDDRA-PT E12 Pneumonia
A44	MEDDRA-PT-ID E12 10035664
A45	CUI E13 C0007642
A46	UMLS-Preferred-Name E13 Cellulitis
A47	MEDDRA-PT E13 Cellulitis
A48	MEDDRA-PT-ID E13 10007882
A49	CUI E14 C0000833
A50	UMLS-Preferred-Name E14 Abscess
A51	MEDDRA-PT E14 Abscess
A52	MEDDRA-PT-ID E14 10000269
A53	CUI E15 C0029118
A54	UMLS-Preferred-Name E15 Opportunistic Infections
A55	MEDDRA-PT E15 Opportunistic infection
A56	MEDDRA-PT-ID E15 10030901
A57	CUI E16 C0041296
A58	UMLS-Preferred-Name E16 Tuberculosis
A59	MEDDRA-PT E16 Tuberculosis
A60	MEDDRA-PT-ID E16 10044755
A61	CUI E17 C1262313
A62	UMLS-Preferred-Name E17 Invasive mycosis
A63	MEDDRA-PT E17 Systemic mycosis
A64	MEDDRA-PT-ID E17 10052366
A65	LLT E17 Invasive mycosis
A66	LLT-ID E17 10062642
A67	CUI E18 C0041296
A68	UMLS-Preferred-Name E18 Tuberculosis
A69	MEDDRA-PT E18 Tuberculosis
A70	MEDDRA-PT-ID E18 10044755
A71	LLT E18 TB
A72	LLT-ID E18 10043148
A73	CUI E19 C0041327
A74	UMLS-Preferred-Name E19 Tuberculosis, Pulmonary
A75	MEDDRA-PT E19 Pulmonary tuberculosis
A76	MEDDRA-PT-ID E19 10037440
A77	LLT E19 Pulmonary TB
A78	LLT-ID E19 10037435
A79	CUI E20 C0679362
A80	UMLS-Preferred-Name E20 Tuberculosis, extrapulmonary
A81	MEDDRA-PT E20 Extrapulmonary tuberculosis
A82	MEDDRA-PT-ID E20 10064445
A83	CUI E21 C3714514
A84	UMLS-Preferred-Name E21 Infection
A85	MEDDRA-PT E21 Infection
A86	MEDDRA-PT-ID E21 10021789
A87	CUI E22 C3714514
A88	UMLS-Preferred-Name E22 Infection
A89	MEDDRA-PT E22 Infection
A90	MEDDRA-PT-ID E22 10021789
A91	CUI E24 C3714514
A92	UMLS-Preferred-Name E24 Infection
A93	MEDDRA-PT E24 Infection
A94	MEDDRA-PT-ID E24 10021789
A95	CUI E26 C0151332
A96	UMLS-Preferred-Name E26 Active tuberculosis
A97	MEDDRA-PT E26 Tuberculosis
A98	MEDDRA-PT-ID E26 10044755
A99	LLT E26 Active tuberculosis
A100	LLT-ID E26 10071157
A101	CUI E27 C0029118
A102	UMLS-Preferred-Name E27 Opportunistic Infections
A103	MEDDRA-PT E27 Opportunistic infection
A104	MEDDRA-PT-ID E27 10030901
A105	CUI E28 C1306459
A106	UMLS-Preferred-Name E28 Primary malignant neoplasm
A107	MEDDRA-PT E28 Neoplasm malignant
A108	MEDDRA-PT-ID E28 10028997
A109	CUI E29 C0024299
A110	UMLS-Preferred-Name E29 Lymphoma
A111	MEDDRA-PT E29 Lymphoma
A112	MEDDRA-PT-ID E29 10025310
A113	CUI E30 C0699893
A114	UMLS-Preferred-Name E30 Skin carcinoma
A115	MEDDRA-PT E30 Skin cancer
A116	MEDDRA-PT-ID E30 10040808
A117	LLT E30 Cancer of skin (excl melanoma)
A118	LLT-ID E30 10007116
A119	CUI E31 C0699893
A120	UMLS-Preferred-Name E31 Skin carcinoma
A121	MEDDRA-PT E31 Skin cancer
A122	MEDDRA-PT-ID E31 10040808
A123	LLT E31 Cancer of skin (excl melanoma)
A124	LLT-ID E31 10007116
A125	CUI E32 C0024299
A126	UMLS-Preferred-Name E32 Lymphoma
A127	MEDDRA-PT E32 Lymphoma
A128	MEDDRA-PT-ID E32 10025310
A129	CUI E33 C0699893
A130	UMLS-Preferred-Name E33 Skin carcinoma
A131	MEDDRA-PT E33 Skin cancer
A132	MEDDRA-PT-ID E33 10040808
A133	LLT E33 Cancer of skin (excl melanoma)
A134	LLT-ID E33 10007116
A135	CUI E35 C0086565
A136	UMLS-Preferred-Name E35 Liver Dysfunction
A137	MEDDRA-PT E35 Hepatic function abnormal
A138	MEDDRA-PT-ID E35 10019670
A139	CUI E36 C0162557
A140	UMLS-Preferred-Name E36 Liver Failure, Acute
A141	MEDDRA-PT E36 Acute hepatic failure
A142	MEDDRA-PT-ID E36 10000804
A143	LLT E36 Acute liver failure
A144	LLT-ID E36 10049844
A145	CUI E38 C0151905
A146	UMLS-Preferred-Name E38 Alanine aminotransferase increased
A147	MEDDRA-PT E38 Alanine aminotransferase increased
A148	MEDDRA-PT-ID E38 10001551
A149	LLT E38 ALT increased
A150	LLT-ID E38 10001845
A151	CUI E40 C0151905
A152	UMLS-Preferred-Name E40 Alanine aminotransferase increased
A153	MEDDRA-PT E40 Alanine aminotransferase increased
A154	MEDDRA-PT-ID E40 10001551
A155	LLT E40 ALT increased
A156	LLT-ID E40 10001845
A157	CUI E43 C0004366
A158	UMLS-Preferred-Name E43 Autoimmune Response
A159	MEDDRA-PT E43 Autoimmune disorder
A160	MEDDRA-PT-ID E43 10061664
A161	CUI E44 C0919715
A162	UMLS-Preferred-Name E44 Lupus-like syndrome
A163	MEDDRA-PT E44 Lupus-like syndrome
A164	MEDDRA-PT-ID E44 10050551
A165	CUI E45 C0151480
A166	UMLS-Preferred-Name E45 Anti-nuclear factor positive
A167	MEDDRA-PT E45 Antinuclear antibody positive
A168	MEDDRA-PT-ID E45 10060055
A169	LLT E45 ANA positive
A170	LLT-ID E45 10060060
A171	CUI E48 C2747927
A172	UMLS-Preferred-Name E48 Anti-dsDNA antibody positive
A173	MEDDRA-PT E48 Double stranded DNA antibody positive
A174	MEDDRA-PT-ID E48 10069907
A175	LLT E48 Anti-dsDNA antibody positive
A176	LLT-ID E48 10069914
A177	CUI E49 C0948715
A178	UMLS-Preferred-Name E49 Infusion related reaction
A179	MEDDRA-PT E49 Infusion related reaction
A180	MEDDRA-PT-ID E49 10051792
A181	CUI E50 C0015230
A182	UMLS-Preferred-Name E50 Exanthema
A183	MEDDRA-PT E50 Rash
A184	MEDDRA-PT-ID E50 10037844
A185	CUI E52 C0948715
A186	UMLS-Preferred-Name E52 Infusion related reaction
A187	MEDDRA-PT E52 Infusion related reaction
A188	MEDDRA-PT-ID E52 10051792
A189	CUI E53 C0041912
A190	UMLS-Preferred-Name E53 Upper Respiratory Infections
A191	MEDDRA-PT E53 Upper respiratory tract infection
A192	MEDDRA-PT-ID E53 10046306
A193	CUI E54 C0041912
A194	UMLS-Preferred-Name E54 Upper Respiratory Infections
A195	MEDDRA-PT E54 Upper respiratory tract infection
A196	MEDDRA-PT-ID E54 10046306
A197	CUI E55 C0027441
A198	UMLS-Preferred-Name E55 Nasopharyngitis
A199	MEDDRA-PT E55 Nasopharyngitis
A200	MEDDRA-PT-ID E55 10028810
A201	CUI E56 C0031350
A202	UMLS-Preferred-Name E56 Pharyngitis
A203	MEDDRA-PT E56 Pharyngitis
A204	MEDDRA-PT-ID E56 10034835
A205	CUI E57 C0023067
A206	UMLS-Preferred-Name E57 Laryngitis
A207	MEDDRA-PT E57 Laryngitis
A208	MEDDRA-PT-ID E57 10023874
A209	CUI E58 C0035455
A210	UMLS-Preferred-Name E58 Rhinitis
A211	MEDDRA-PT E58 Rhinitis
A212	MEDDRA-PT-ID E58 10039083
A213	CUI E59 C0042769
A214	UMLS-Preferred-Name E59 Virus Diseases
A215	MEDDRA-PT E59 Viral infection
A216	MEDDRA-PT-ID E59 10047461
A217	CUI E60 C0021400
A218	UMLS-Preferred-Name E60 Influenza
A219	MEDDRA-PT E60 Influenza
A220	MEDDRA-PT-ID E60 10022000
A221	CUI E61 C0019340
A222	UMLS-Preferred-Name E61 Herpes NOS
A223	MEDDRA-PT E61 Herpes virus infection
A224	MEDDRA-PT-ID E61 10019973
A225	LLT E61 Herpes NOS
A226	LLT-ID E61 10019944
A227	CUI E62 C0004623
A228	UMLS-Preferred-Name E62 Bacterial Infections
A229	MEDDRA-PT E62 Bacterial infection
A230	MEDDRA-PT-ID E62 10060945
A231	CUI E63 C0006277
A232	UMLS-Preferred-Name E63 Bronchitis
A233	MEDDRA-PT E63 Bronchitis
A234	MEDDRA-PT-ID E63 10006451
A235	CUI E64 C0042373
A236	UMLS-Preferred-Name E64 Vascular Diseases
A237	MEDDRA-PT E64 Angiopathy
A238	MEDDRA-PT-ID E64 10059245
A239	LLT E64 Vascular disorder
A240	LLT-ID E64 10047059
A241	CUI E65 C0020538
A242	UMLS-Preferred-Name E65 Hypertensive disease
A243	MEDDRA-PT E65 Hypertension
A244	MEDDRA-PT-ID E65 10020772
A245	CUI E66 C0015230
A246	UMLS-Preferred-Name E66 Exanthema
A247	MEDDRA-PT E66 Rash
A248	MEDDRA-PT-ID E66 10037844
A249	CUI E67 C0015967
A250	UMLS-Preferred-Name E67 Fever
A251	MEDDRA-PT E67 Pyrexia
A252	MEDDRA-PT-ID E67 10037660
A253	CUI E70 C0018939
A254	UMLS-Preferred-Name E70 Hematological Disease
A255	MEDDRA-PT E70 Blood disorder
A256	MEDDRA-PT-ID E70 10061590
A257	CUI E71 C0024228
A258	UMLS-Preferred-Name E71 Lymphatic Diseases
A259	MEDDRA-PT E71 Lymphatic disorder
A260	MEDDRA-PT-ID E71 10052314
A261	CUI E72 C0026946
A262	UMLS-Preferred-Name E72 Mycoses
A263	MEDDRA-PT E72 Fungal infection
A264	MEDDRA-PT-ID E72 10017533
A265	CUI E73 C0037199
A266	UMLS-Preferred-Name E73 Sinusitis
A267	MEDDRA-PT E73 Sinusitis
A268	MEDDRA-PT-ID E73 10040753
A269	CUI E74 C0000833
A270	UMLS-Preferred-Name E74 Abscess
A271	MEDDRA-PT E74 Abscess
A272	MEDDRA-PT-ID E74 10000269
A273	CUI E75 C0149725
A274	UMLS-Preferred-Name E75 Lower respiratory tract infection
A275	MEDDRA-PT E75 Lower respiratory tract infection
A276	MEDDRA-PT-ID E75 10024968
A277	CUI E76 C0032285
A278	UMLS-Preferred-Name E76 Pneumonia
A279	MEDDRA-PT E76 Pneumonia
A280	MEDDRA-PT-ID E76 10035664
A281	CUI E77 C0034186
A282	UMLS-Preferred-Name E77 Pyelonephritis
A283	MEDDRA-PT E77 Pyelonephritis
A284	MEDDRA-PT-ID E77 10037596
A285	CUI E78 C0151905
A286	UMLS-Preferred-Name E78 Alanine aminotransferase increased
A287	MEDDRA-PT E78 Alanine aminotransferase increased
A288	MEDDRA-PT-ID E78 10001551
A289	CUI E79 C0151904
A290	UMLS-Preferred-Name E79 Aspartate aminotransferase increased
A291	MEDDRA-PT E79 Aspartate aminotransferase increased
A292	MEDDRA-PT-ID E79 10003481
A293	CUI E80 C0853697
A294	UMLS-Preferred-Name E80 Neutrophil count decreased
A295	MEDDRA-PT E80 Neutrophil count decreased
A296	MEDDRA-PT-ID E80 10029366
A297	CUI E81 C0012833
A298	UMLS-Preferred-Name E81 Dizziness
A299	MEDDRA-PT E81 Dizziness
A300	MEDDRA-PT-ID E81 10013573
A301	CUI E82 C0030554
A302	UMLS-Preferred-Name E82 Paresthesia
A303	MEDDRA-PT E82 Paraesthesia
A304	MEDDRA-PT-ID E82 10033775
A305	LLT E82 Paresthesia
A306	LLT-ID E82 10033987
A307	CUI E83 C0009806
A308	UMLS-Preferred-Name E83 Constipation
A309	MEDDRA-PT E83 Constipation
A310	MEDDRA-PT-ID E83 10010774
A311	CUI E84 C0025202
A312	UMLS-Preferred-Name E84 melanoma
A313	MEDDRA-PT E84 Malignant melanoma
A314	MEDDRA-PT-ID E84 10025650
A315	LLT E84 Melanoma
A316	LLT-ID E84 10053571
A317	CUI E85 C1736167
A318	UMLS-Preferred-Name E85 Systemic allergic reaction
A319	MEDDRA-PT E85 Hypersensitivity
A320	MEDDRA-PT-ID E85 10020751
A321	LLT E85 Systemic allergic reaction
A322	LLT-ID E85 10066472
A323	CUI E86 C0002792
A324	UMLS-Preferred-Name E86 anaphylaxis
A325	MEDDRA-PT E86 Anaphylactic reaction
A326	MEDDRA-PT-ID E86 10002198
A327	CUI E87 C0036202
A328	UMLS-Preferred-Name E87 Sarcoidosis
A329	MEDDRA-PT E87 Sarcoidosis
A330	MEDDRA-PT-ID E87 10039486
A331	CUI E88 C0206062
A332	UMLS-Preferred-Name E88 Lung Diseases, Interstitial
A333	MEDDRA-PT E88 Interstitial lung disease
A334	MEDDRA-PT-ID E88 10022611
A335	CUI E89 C0237849
A336	UMLS-Preferred-Name E89 Peeling of skin
A337	MEDDRA-PT E89 Skin exfoliation
A338	MEDDRA-PT-ID E89 10040844
A339	CUI E90 C0085932
A340	UMLS-Preferred-Name E90 Skin Diseases, Bullous
A341	MEDDRA-PT E90 Dermatitis bullous
A342	MEDDRA-PT-ID E90 10012441
A343	CUI E92 C0041296
A344	UMLS-Preferred-Name E92 Tuberculosis
A345	MEDDRA-PT E92 Tuberculosis
A346	MEDDRA-PT-ID E92 10044755
A347	LLT E92 TB
A348	LLT-ID E92 10043148
A349	CUI E93 C0041296
A350	UMLS-Preferred-Name E93 Tuberculosis
A351	MEDDRA-PT E93 Tuberculosis
A352	MEDDRA-PT-ID E93 10044755
A353	LLT E93 TB
A354	LLT-ID E93 10043148
A355	CUI E95 C3714514
A356	UMLS-Preferred-Name E95 Infection
A357	MEDDRA-PT E95 Infection
A358	MEDDRA-PT-ID E95 10021789
A359	CUI E96 C0006826
A360	UMLS-Preferred-Name E96 Malignant Neoplasms
A361	MEDDRA-PT E96 Neoplasm malignant
A362	MEDDRA-PT-ID E96 10028997
A363	CUI E98 C0023530
A364	UMLS-Preferred-Name E98 Leukopenia
A365	MEDDRA-PT E98 Leukopenia
A366	MEDDRA-PT-ID E98 10024384
